Clinical trial
LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in…
NCT00328588 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00328588 |
|---|---|
| Title | LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer, Cancer of Lung, Cancer of the Lung, Non-Small Cell Lung Carcinoma, Carcinoma, Non-Small Cell Lung |
| Intervention type | Drug |
| Interventions | YM155 |
| Enrollment | 37 |
| Start date | Dec 1, 2006 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | May 22, 2006 |
| Last update posted | Jan 2, 2008 |
| Countries | Czechia, Germany, Netherlands |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: